{"title":"GWAS的见解可以帮助将基因与药物治疗联系起来","authors":"Alison Knopf","doi":"10.1002/cpu.30950","DOIUrl":null,"url":null,"abstract":"<p>The genetic risk for psychiatric disorders may be separate from the way symptoms are currently targeted for certain pharmacologic treatments, according to a recent bioinformatic study. Rather, using the approach of a genome-wide association study (GWAS) could better link risk genes to the best pharmacologic treatments.</p>","PeriodicalId":22496,"journal":{"name":"The Brown University Child & Adolescent Psychopharmacology Update","volume":"27 4","pages":"1-3"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"GWAS insights can help link genes to pharmacologic treatments\",\"authors\":\"Alison Knopf\",\"doi\":\"10.1002/cpu.30950\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The genetic risk for psychiatric disorders may be separate from the way symptoms are currently targeted for certain pharmacologic treatments, according to a recent bioinformatic study. Rather, using the approach of a genome-wide association study (GWAS) could better link risk genes to the best pharmacologic treatments.</p>\",\"PeriodicalId\":22496,\"journal\":{\"name\":\"The Brown University Child & Adolescent Psychopharmacology Update\",\"volume\":\"27 4\",\"pages\":\"1-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Child & Adolescent Psychopharmacology Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cpu.30950\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Child & Adolescent Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpu.30950","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
GWAS insights can help link genes to pharmacologic treatments
The genetic risk for psychiatric disorders may be separate from the way symptoms are currently targeted for certain pharmacologic treatments, according to a recent bioinformatic study. Rather, using the approach of a genome-wide association study (GWAS) could better link risk genes to the best pharmacologic treatments.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
